Roger B. Fillingim

Professor | Director University of Florida

Gainesville FL

Roger B. Fillingim maintains an active research program investigating individual differences in pain.

Contact

University of Florida
View more experts managed by University of Florida

View all Experts

Biography

Roger B. Fillingim is a clinical psychologist and distinguished professor in the College of Dentistry. He also is the director of the UF Pain Research & Intervention Center of Excellence. Roger maintains an active research program investigating individual differences in pain. He serves as director of the UF Center for Advancing Minority Pain and Aging Science.

Areas of Expertise

Ethnic Group Differences in Pain

Pain

Articles

Associations between Vitamin D, Omega 6:Omega 3 Ratio, and Biomarkers of Aging in Individuals Living with and without Chronic Pain

nutrients

Akemi T. Wijayabahu, et al.

2021-12-15

Elevated inflammatory cytokines and chronic pain are associated with shorter leukocyte telomere length (LTL), a measure of cellular aging. Micronutrients, such as 25-hydroxyvitamin D (vitamin D) and omega 3, have anti-inflammatory properties. Little is known regarding the relationships between vitamin D, omega 6:3 ratio, LTL, inflammation, and chronic pain.

A Mediation Appraisal of Catastrophizing, Pain-Related Outcomes, and Race in Adults With Knee Osteoarthritis

The journal of pain

Dottington Fullwood, et al.

2021-05-24

The current cross-sectional study investigates whether pain catastrophizing mediates the relationship between ethnicity/race and pain, disability and physical function in individuals with knee osteoarthritis. Furthermore, this study examined mediation at 2-year follow-up. Participants included 187 community-dwelling adults with unilateral or bilateral knee pain who screened positive for knee osteoarthritis.

A hybrid implementation-effectiveness randomized trial of CYP2D6-guided postoperative pain management

Genetics in Medicine

Cameron D. Thomas, et al.

2021-01-08

Cytochrome P450 2D6 (CYP2D6) genotype-guided opioid prescribing is limited. The purpose of this type 2 hybrid implementation-effectiveness trial was to evaluate the feasibility of clinically implementing CYP2D6-guided postsurgical pain management and determine that such an approach did not worsen pain control.